View Older Stories View More Recent Stories
-
Oracle Health and ID.me to integrate digital identity tools for patients
-
Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
-
Oracle adds digital asset banking tools with AI and ISO 20022 support
-
Oracle Health announces AI tools for healthcare revenue cycle management
-
Oracle and Buck Institute to collaborate on aging research data
-
Oracle and Wipro partner on cloud pharmacovigilance services
-
Oracle (ORCL) call put ratio 3.2 calls to 1 put
-
Oracle (ORCL) Reiterated at Buy by Stifel as New Mexico Project Construction 26% Complete
-
San Juan Regional adopts Oracle Health tools to improve bed management
-
Popular stocks with increasing option volume: SMCI ORCL GOOGL PLTR GME MSTR SOFI NBIS AVGO HOOD
-
Oracle Commodity Holding Reports Annual General and Special Meeting Results
-
Active options: ORCL PLTR AVGO MSFT GOOGL MSTR IREN CRWD SOFI HOOD COIN
-
Oracle releases Java 27 with post-quantum cryptography support
-
Mizuho Reiterates Outperform Rating on Oracle (ORCL)
-
Oracle (ORCL) PT Lowered to $205 at Freedom Broker
-
Oracle (ORCL) spreader of March 170 and 200 calls as share price down 4.4%
-
Popular stocks: ORCL SPCX MU INTC MSTR SMCI MARA DELL PLTR GME HOOD SNDK
-
Oracle shares fall amid job cuts
-
Oracle Starts A New Round Of Layoffs - Business Insider
-
Oracle launches AI agent for nurses to cut documentation time
-
Popular stocks with increasing option volume: ORCL MU SPCX INTC MSTR SMCI DELL MARA PLTR HOOD SNDK GME
-
Oracle (ORCL) call put ratio 2.3 calls to 1 put into share price lower before the bell
-
Larry Ellison cancels plan to sell Oracle stock
-
Popular stocks with increasing option volume: ORCL MU SPCX INTC MSTR SMCI DELL MARA PLTR HOOD SNDK GME
-
Oracle (ORCL) call put ratio 2.4 calls to 1 put with a focus on October 165 calls
-
Popular stocks: ORCL INTC MSTR SPCX MU GME HOOD CRWV IREN ADBE AVGO
-
DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
-
Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'
-
Oracle (ORCL) PT Lowered to $200 at Stifel, Buy Rating Maintained
-
Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
-
Oracle (ORCL) Reiterated at Overweight by Cantor Fitzgerald on Strong Q1 Results
-
Oppenheimer on Oracle (ORCL): 'Some Relief from the Financing Concerns'
-
Guggenheim Reiterates Buy Rating on Oracle (ORCL)
-
Stocks expected to have increasing option volume: ORCL ADBE KR RH GME CPRT ACVA BHF ZUMZ CW CELH
-
Oracle (ORCL) Reiterated at Market Outperform by Citizens on Q1 Results
-
After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
-
Oracle raises full year profit guidance, stock rises after hours
-
Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
-
Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
-
Popular stocks with increasing option volume: SPCX MU INTC ORCL MSTR CRWV UBER PCG HOOD SOFI
-
Oracle (ORCL) September 11 weekly 160 calls active into quarter results
-
Oracle FQ1 earnings preview: Mizuho flags what could drive the print
-
Oracle reports earnings today: AI spending bet faces its toughest test yet
-
Oracle (ORCL) call put ratio 1.9 calls to 1 put into quarter results after the bell
-
Stocks expected to have increasing option volume: ORCL ADBE M RH AEO SKIL KR FIZZ
-
Oracle (ORCL) call put ratio 2.7 calls to 1 put with a focus on September 11 weekly 165 calls into quarter results
-
TD Cowen Previews Oracle (ORCL) Earnings: 'We remain constructive on ORCL's risk/reward'
-
Oracle (ORCL) call put ratio 2 calls to 1 put into quarter results
-
Stocks expected to have increasing option volume: ORCL CASY BRZE TTAN PBR RH OWL
-
Oracle (ORCL) Reiterated at Market Outperform by Citizens on Positive Due Diligence Results
